| 000 | 01160 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513230205.0 | ||
| 264 | 0 | _c20010329 | |
| 008 | 200103s 0 0 dut d | ||
| 022 | _a0028-2162 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimoons, M L | |
| 245 | 0 | 0 |
_a[Cholesterol-lowering therapy; a recommendation from the Health Council]. _h[electronic resource] |
| 260 |
_bNederlands tijdschrift voor geneeskunde _cDec 2000 |
||
| 300 |
_a2442-4 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArteriosclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aCoronary Disease _xetiology |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHypercholesterolemia _xdiagnosis |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 773 | 0 |
_tNederlands tijdschrift voor geneeskunde _gvol. 144 _gno. 51 _gp. 2442-4 |
|
| 999 |
_c11091448 _d11091448 |
||